Specialists in Pharmaceutical regulatory affairs, product development and eCTD preparations

Med-Script Associates Ltd. and Med-Script Development Inc. are privately owned Canadian companies, specializing in pharmaceutical regulatory affairs, services in research and development (R&D) and eCTD preparation.


Med-Script Associates Ltd., founded in 1972, prepares, files and supports all types of drug submissions, including clinical trial applications and submissions for new drugs, biologics, generics, natural health products and medical devices. Med-Script Development has expertise in eCTD preparations of drug submissions, utilizing its own fully validated eCTD software.

Contact Us

Regulatory Affairs

Med-Script Associates Ltd. and its sister company, Med-Script Development Inc., offer comprehensive services for pharmaceutical R&D, all types of drug submissions to national regulatory agencies and validated eCTD preparation of these submissions.


Med-Script Associates Ltd. has gained approval of hundreds of drug submissions, starting with Clinical Trial Applications to New Drug Submissions for innovative drugs and biologics, Abbreviated New Drug Submissions for generic drugs, Supplements and Medical Device Submissions.

eCTD (electronic Common Technical Document) Expertise

Med-Script Development Inc. was founded in 2014. It utilizes software that was developed in house, which allows for significant cost savings over the commercial suppliers of eCTD services. Health Canada now mandates that all drug submissions be filed electronically, according to very specific requirements. The software developed by Med-Script Development experts has been fully validated by Health Canada. The company has successfully filed numerous submissions electronically for clients since its founding.

R&D Collaboration

Med-Script Associates is frequently asked to provide R&D support by reviewing documentation generated by companies during the development phases of drugs or biologics. Criteria applied by most regulatory agencies are harmonized via an initiative called TheInternational Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals (ICH). Because of this universal application of acceptance criteria for specifications of drug substances and drug products, Med-Script Associates can guide its worldwide clients in the development of acceptable standards and norms for their products.

As part of that global effort, Med-Script is frequently asked to prepare “gap analyses” or detailed reports of the deficiencies in the company’s documentation. This avoids ongoing errors and expedites the generation of documentation that will be universally accepted by the regulatory agencies.

Comprehensive Regulatory Services

Med-Script Associates and Med-Script Development have particular expertise and experience in the requirements of Health Canada and the Canadian Food and Drug Regulations. Both firms collaborate extensively with companies worldwide, who wish to pursue drug submissions in Canada or gain R&D advice during their early and later phases of drug development. We work closely with companies in the United States, the EU countries, Korea and Japan.

www.med-script.com

Office: (450) 458-2284

Fax: (450) 977-0707

wehner@med-script.com

www.med-script.com

Med-Script Associates Ltd.

Med-Script Development Inc.

176 chemin St. Henri

Ste. Marthe, Quebec

Canada, J0P 1W0

Go to article: Home | The Dawn of Big DataGo to article: EditorialGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: ContentsGo to article: Daiichi JitsugyoGo to article: How will Amazon's acquisition of online pharmacy business PillPack disrupt the pharmaceutical industry? Go to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Fentanyl: where did it all go wrong?Go to article: NSFGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: Turning up the heat on nano researchGo to article: TSS Company InsightGo to article: TSS ABGo to article: MedelpharmGo to article: Cracking the mystery of Alzheimer's diseaseGo to article: Röchling Medical NeuhausGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: Where are the world's pharma manufacturing hotspots?Go to article: Gerteis Company InsightGo to article: GerteisGo to article: ZenatekGo to article: How India’s use of unapproved antibiotics could undermine global healthGo to article: Novo Nordisk PharmatechGo to article: Phoenix Company InsightGo to article: PhoenixGo to article: CRISPR: a seismic shift in gene editingGo to article: CBDepot Company InsightGo to article: CBDepotGo to article: Is the UK’s drug evaluation system in need of an overhaul?Go to article: Nelson Labs Company InsightGo to article: Nelson LabsGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Opening up the Chinese drug marketGo to article: Finnair Cargo | Company InsightGo to article: Finnair CargoGo to article: Immunising against opioids – could a vaccine solve the crisis? Go to article: Molnar Company InsightGo to article: MolnarGo to article: PharmasolGo to article: The next generation of antimalarials Go to article: Oncology Therapeutic Development Company InsightGo to article: Oncology Therapeutic DevelopmentGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: The People vs Big Pharma: tackling the industry’s trust issuesGo to article: G.F.Go to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: Amazon and PillPack: an unstoppable pharmacy force?Go to article: BEAGo to article: Buchi Labortechnik AG Company InsightGo to article: Buchi Labortechnik AGGo to article: Is the microbiome as important for precision medicine as genetics?Go to article: Medical HempGo to article: Senn ChemicalsGo to article: Senn ChemicalsGo to article: Niconex Medical LtdGo to article: HPV vaccines: a decade of progressGo to article: Med-Script AssociatesGo to article: B&W Tek | Company InsightGo to article: B&W TekGo to article: EventsGo to article: CG ChemikalienGo to article: AlpexGo to article: Next issueGo to article: Pall Biotech Company InsightGo to article: CrewpharmGo to article: EndocaGo to article: Diversey